Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03439280
Title A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope - Duarte Duarte California 91010 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center New York New York 10011 United States Details
Weill Cornell Medical Center, Div. of Hematology Medical Oncology New York New York 10065 United States Details
Oregon Health & Science University Knight Cancer Institute Portland Oregon 97239 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field